Related Experiment Video
Updated: Jan 24, 2026

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells
Published on: March 7, 2025
Profile analysis reveals transfer RNA fragments involved in mesangial cells proliferation
Xiaoyu Lu1, Xianyi Zhu1, Minyi Yu1
1Department of Pediatric Nephrology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210003, China.
Abstract:
Mesangial cell (MCs) proliferation is an essential component of glomerulonephritis. To find some bio-markers of mesangial cell proliferation, we investigate the relationship between transfer RNA fragments (tRFs) and proliferating mesangial cells. The model of proliferating mesangial cells was built by using transforming growth factor-1(TGF-β1) treated mesangial cells. Then we analyzed the expression of tRFs in normal mesangial cells and mesangial cells treated by TGF-β1 through high-throughput sequencing technique. qRT-PCR was conducted to validate the differently expressed tRFs in normal mesangial cells and mesangial cells treated by TGF-β1. tDR-000064 and tDR-000103 were notably down-regulated in mesangial cells treated by TGF-β1 compared with normal mesangial cells. Then we confirmed that tDR-000064 and tDR-000103 were correlated with proliferation of mesangial cells through receiver operating characteristic curve analysis. Furthermore, Gene ontology (GO) and pathway analysis demonstrated that the two dys-regulated tRFs were mostly involved in mesangial cells and TGF-β1 receptor-mediated signaling pathway. Our research provides a comprehensive analysis of tRFs in proliferating mesangial cells. (Figure 1A).
Insights
Transfer RNA fragments (tRFs) were investigated as biomarkers for mesangial cell proliferation in glomerulonephritis. Two specific tRFs, tDR-000064 and tDR-000103, were found to be down-regulated and correlated with mesangial cell proliferation.
Area of Science:
- Molecular Biology
- Genetics
- Nephrology
Background:
- Mesangial cell (MC) proliferation is a key factor in glomerulonephritis pathogenesis.
- Identifying reliable biomarkers for MC proliferation is crucial for understanding and treating kidney diseases.
Purpose of the Study:
- To investigate the role of transfer RNA fragments (tRFs) as potential biomarkers for mesangial cell proliferation.
- To analyze the differential expression of tRFs in proliferating mesangial cells.
Main Methods:
- Mesangial cells were treated with transforming growth factor-beta 1 (TGF-β1) to induce proliferation.
- High-throughput sequencing was employed to analyze tRF expression profiles.
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used for validation.
- Receiver operating characteristic (ROC) curve analysis was performed to assess diagnostic potential.
- Gene Ontology (GO) and pathway analysis were conducted.
Main Results:
- Two tRFs, tDR-000064 and tDR-000103, were significantly down-regulated in TGF-β1-treated (proliferating) mesangial cells compared to normal mesangial cells.
- tDR-000064 and tDR-000103 expression levels were correlated with mesangial cell proliferation.
- GO and pathway analysis indicated involvement of these tRFs in MCs and TGF-β1 receptor-mediated signaling.
Conclusions:
- tDR-000064 and tDR-000103 are potential biomarkers for mesangial cell proliferation.
- These findings contribute to understanding the molecular mechanisms of glomerulonephritis.
- Further research into tRFs could offer novel therapeutic targets for kidney diseases.
Related Concept Videos
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Transfer RNA Synthesis
Habitat Fragmentation
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

